Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

HIV Lipodystrophy: early-phase trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

HIV Lipodystrophy: 2 US clinical trials tracked, none currently recruiting.

HIV Lipodystrophy is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Medical University of South Carolina, running 1 of these trials.

Enrollment posture brief

Registry condition hiv-lipodystrophy

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%HIV Lipodystrophy (this)0%
Open-enrollment share among volume-matched conditions near HIV Lipodystrophy

HIV Lipodystrophy has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for HIV Lipodystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. HIV Lipodystrophy is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on HIV Lipodystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

13 valent conjugated pneumococcal vaccine Biological
1 trials
Pneumococcal polysaccharide vaccine 23 valent Biological
1 trials
Human recombinant leptin ("metreleptin") Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on HIV Lipodystrophy trials. A trial with sites in several states counts in each.

Texas 1 trials
South Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this HIV Lipodystrophy page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HIV Lipodystrophy condition card totals 2 registered trials; most-linked intervention 13 valent conjugated pneumococcal vaccine; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.